The first enzyme in the de novo serine synthesis pathway (SSP)—phosphoglycerate dehydrogenase (PHGDH) is found up-regulated in melanoma and breast cancers through genomic amplification by increasing the copy number of the gene, which adequately support cancer cell growth in the absence of serine (93, 94). Here, PHGDH is linked to cancer.